Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Obesity as a Medical Condition More healthcare professionals now recognize obesity as a chronic disease requiring medical intervention rather than just lifestyle changes
The Most Overlooked Factor: Fit Most online comparisons focus on efficacy data
Main outcomes are indexes of insulin secretion and sensitivity and distribution of body fat as main determinants of response or nonresponse to an LI
Potentially life-threatening
In a direct comparison, the dual agonists DA4-JC and DA5-CH were able to cross the BBB much better than standard GLP-1 receptor agonists, such as exendin-4, liraglutide, and semaglutide (Zhang et al., 2020)
US$ 20.46
US$ 21.08
US$ 26.16
